Acquisition by Carlson Peter M of 35211 shares of MIMEDX GROUP subject to Rule 16b-3


USD 2.95  0.11  3.59%   

Filed transaction by Mimedx Group Inc officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)
Published over a year ago
View all stories for Mimedx | View All Stories
Transaction by Carlson Peter M

How important is Mimedx's Liquidity

Mimedx financial leverage refers to using borrowed capital as a funding source to finance Mimedx Group ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Mimedx financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Mimedx's total debt and its cash.

How does Mimedx utilize its cash?

To perform a cash flow analysis of Mimedx, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Mimedx is receiving and how much cash it distributes out in a given period. The Mimedx cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities.


MIMEDX insider trading alert for grant of common stock by Carlson Peter M, Chief Financial Officer, on 7th of July 2020. This event was filed by Mimedx Group Inc with SEC on 2020-07-07. Statement of changes in beneficial ownership - SEC Form 4